Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphocyte Disorder T”

676 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 676 results

Testing effectiveness (Phase 2)UnknownNCT00242515
What this trial is testing

T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
National University Hospital, Singapore 16
Early research (Phase 1)Study completedNCT00006340
What this trial is testing

Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

Who this might be right for
LeukemiaLymphomaPrecancerous Condition+1 more
Boston Medical Center
Testing effectiveness (Phase 2)Study completedNCT06390748
What this trial is testing

Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes

Who this might be right for
SepsisLymphocyte Disorder TImmunologic Paralysis+4 more
Lin Chen 150
Testing effectiveness (Phase 2)Study completedNCT00929578
What this trial is testing

Fluphenazine Hydrochloride for Psoriasis

Who this might be right for
Psoriasis
Tufts Medical Center 15
Not applicableStudy completedNCT00610597
What this trial is testing

Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease

Who this might be right for
Alcoholic Liver DiseaseChronic Hepatitis C Virus
Erasme University Hospital 49
Not applicableStudy completedNCT00179075
What this trial is testing

Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic Stem Cell TransplantationGraft vs Host Disease
Vanderbilt University 100
Large-scale testing (Phase 3)Active Not RecruitingNCT07000149
What this trial is testing

Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC

Who this might be right for
Advanced Clear Cell Renal Cell Carcinoma
AstraZeneca 1,116
Testing effectiveness (Phase 2)Study completedNCT00104858
What this trial is testing

Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaProlymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+6 more
Fred Hutchinson Cancer Center 66
Early research (Phase 1)Looking for participantsNCT04099797
What this trial is testing

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

Who this might be right for
Diffuse Intrinsic Pontine GliomaHigh Grade GliomaEmbryonal Tumor+1 more
Baylor College of Medicine 37
Large-scale testing (Phase 3)Ended earlyNCT05305040
What this trial is testing

Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Adenovirus InfectionBK Virus InfectionCytomegalovirus Infections+3 more
AlloVir 451
Not applicableStudy completedNCT02092558
What this trial is testing

Evaluation of Immunological Disorders of T Lymphocytes and Endocrinological Disorders as Pathogen Factors in Patients With Metaplasia of Urinary Bladder

Who this might be right for
The Follow-up Duration Was 1-8 Years.The Main Reasons Behind Visiting the Hospital Were Recurrent Urinary Tract Infection,Urinary Urgencies, Pollakiuria, Difficulty in Initiating Micturition, Pain in Hypogastrium,+2 more
Children's Hospital, Dziekanów Leśny, Poland
Early research (Phase 1)Ended earlyNCT00082225
What this trial is testing

LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL)

Who this might be right for
Lymphoma
Baylor College of Medicine 4
Not applicableActive Not RecruitingNCT03728842
What this trial is testing

Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma

Who this might be right for
Melanoma; Renal Cell Carcinoma
Indiana University 19
Testing effectiveness (Phase 2)Ended earlyNCT00278265
What this trial is testing

Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia

Who this might be right for
T-Cell Large Granular Lymphocytic Leukemia
German CLL Study Group 12
Early research (Phase 1)Study completedNCT02200445
What this trial is testing

Low Dose IL-2 for Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Scott B. Snapper, MD PHD 26
Not applicableUnknownNCT04320667
What this trial is testing

Urinary T Cell Biomarker for Prediction in ANCA Glomerulonephritis

Who this might be right for
Glomerulonephritis Acute
Charite University, Berlin, Germany 79
Post-approval studies (Phase 4)UnknownNCT01407211
What this trial is testing

Impact of Vitamin A on Gene Expression, in Multiple Sclerosis Patient

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Tehran University of Medical Sciences 30
Not applicableStudy completedNCT00014053
What this trial is testing

Immune System Activity in Healthy Adults

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)UnknownNCT05538195
What this trial is testing

Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+2 more
Chongqing Precision Biotech Co., Ltd 60
Testing effectiveness (Phase 2)Study completedNCT06865352
What this trial is testing

Safety and Preliminary Efficacy of Donor-derived Anti-leukemia Cytotoxic T Lymphocytes for the Prevention of Leukemia Relapse in Children Given Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia ALLAcute Myeloid Leukemia (AML)
Fondazione IRCCS Policlinico San Matteo di Pavia 15
Load More Results
2